Clearance rates higher with bimekizumab vs. secukinumab in phase 3 psoriasis studyApril 24, 2021Psoriasis
Study aims to enhance understanding of ‘tremendously understudied’ prurigo nodularisApril 16, 2021Medical DermatologyPsoriasisAtopic DermatitisMixed Topics
Secukinumab brings high PASI 75 results in 6- to 17-year-olds with psoriasisApril 12, 2021PsoriasisPediatrics
Researchers stress importance of second COVID-19 vaccine dose for infliximab usersApril 6, 2021COVID-19 UpdatesPsoriatic ArthritisPediatricsPsoriasis
Bimekizumab superior to adalimumab in head-to-head psoriasis studyApril 6, 2021PsoriasisPsoriatic Arthritis
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccineMarch 31, 2021PsoriasisCOVID-19 Updates
To improve psoriatic arthritis outcomes, address common comorbiditiesMarch 12, 2021Psoriatic ArthritisPsoriasis
Recent psoriasis pathophysiology insights carry treatment implicationsMarch 4, 2021PsoriasisPsoriatic Arthritis
Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patientsFebruary 25, 2021PsoriasisPsoriatic Arthritis
Pandemic puts patients with psoriatic disease off seeking medical helpFebruary 23, 2021Psoriatic ArthritisPsoriasisCOVID-19 Updates
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fracturesFebruary 16, 2021Atopic DermatitisPsoriasisMedical Dermatology
Psoriasis registry study finds normal pregnancy outcomesFebruary 12, 2021PsoriasisPsoriatic Arthritis
Expert calls for paradigm shift in lab monitoring of some dermatology drugsFebruary 11, 2021AcneInfectious DiseasesMedical DermatologyPsoriasis
